AnastasiosManiakasMDMSc, FRCSC

Otolaryngology (ENT) • Houston, TX

Head & Neck Oncologic Surgery

Assistant Professor

Join to view full profile

Dr. Maniakas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Maniakas' full profile

Already have an account?

Office
1400 Pressler St
Unit 1445
Houston, TX 77030

Education & Training

University of Montreal Faculty of MedicineClass of 2013

Certifications & Licensure

TX State Medical License 2021 - 2026

Publications & Presentations

PubMed

Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma.
Sarah Hamidi, Sireesha Yedururi, Mimi I Hu, Naifa L Busaidy, Steven I Sherman
Thyroid. 2024-12-04
[18F]-Fluorodeoxyglucose Uptake as a Marker of Residual Anaplastic and Poorly Differentiated Thyroid Carcinoma Following BRAF-Targeted Therapy.
Samir A Dagher, Kim O Learned, Richard Dagher, Jennifer Rui Wang, Xiao Zhao
AJNR. American Journal of Neuroradiology. 2024-11-21
Patterns of loco-regional progression and patient outcomes after definitive-dose radiation therapy for anaplastic thyroid cancer.
Julianna K Bronk, Alexander Augustyn, Abdallah S R Mohamed, C David Fuller, Adam S Garden
Radiotherapy and Oncology. 2024-11-01